Dianthus Therapeutics Statistics

Total Valuation

DNTH has a market cap or net worth of $779.52 million. The enterprise value is $402.98 million.

Market Cap	779.52M
Enterprise Value	402.98M

Important Dates

The next estimated earnings date is Monday, August 5, 2024, before market open.

Earnings Date	Aug 5, 2024
Ex-Dividend Date	n/a

Share Statistics

DNTH has 29.35 million shares outstanding. The number of shares has increased by 2,834.17% in one year.

Shares Outstanding	29.35M
Shares Change (YoY)	+2,834.17%
Shares Change (QoQ)	+398.03%
Owned by Insiders (%)	15.97%
Owned by Institutions (%)	74.01%
Float	n/a

Valuation Ratios

The trailing PE ratio is 6.93.

PE Ratio	6.93
Forward PE	n/a
PS Ratio	345.69
Forward PS	628.90
PB Ratio	2.09
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	178.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 42.52, with a Debt / Equity ratio of 0.00.

Current Ratio	42.52
Quick Ratio	42.18
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -21.30% and return on invested capital (ROIC) is -14.45%.

Return on Equity (ROE)	-21.30%
Return on Assets (ROA)	-20.30%
Return on Capital (ROIC)	-14.45%
Revenue Per Employee	$42,547
Profits Per Employee	-$799,208
Employee Count	53
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	25.11
200-Day Moving Average	19.56
Relative Strength Index (RSI)	50.15
Average Volume (20 Days)	431,971

Short Selling Information

The latest short interest is 2.34 million, so 7.98% of the outstanding shares have been sold short.

Short Interest	2.34M
Short Previous Month	1.97M
Short % of Shares Out	7.98%
Short % of Float	n/a
Short Ratio (days to cover)	1.19

Income Statement

In the last 12 months, DNTH had revenue of $2.26 million and -$42.36 million in losses.

Revenue	2.26M
Gross Profit	2.26M
Operating Income	-53.93M
Pretax Income	-42.36M
Net Income	-42.36M
EBITDA	-43.10M
EBIT	-42.36M
Earnings Per Share (EPS)	$3.83

Full Income Statement

Balance Sheet

The company has $377.04 million in cash and $497,000 in debt, giving a net cash position of $376.54 million or $12.83 per share.

Cash & Cash Equivalents	377.04M
Total Debt	497,000
Net Cash	376.54M
Net Cash Per Share	$12.83
Equity (Book Value)	372.69M
Book Value Per Share	12.70
Working Capital	371.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.20 million and capital expenditures -$1.41 million, giving a free cash flow of -$17.61 million.

Operating Cash Flow	-16.20M
Capital Expenditures	-1.41M
Free Cash Flow	-17.61M
FCF Per Share	-$0.69

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,391.75% and -1,878.40%.

Gross Margin	100.00%
Operating Margin	-2,391.75%
Pretax Margin	-1,878.40%
Profit Margin	-1,878.40%
EBITDA Margin	-1,911.44%
EBIT Margin	-1,878.40%
FCF Margin	-780.84%

Dividends & Yields

DNTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,834.17%
Shareholder Yield	-2,834.17%
Earnings Yield	-5.43%
FCF Yield	-2.26%

Analyst Forecast

The average price target for DNTH is $42.40, which is 59.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$42.40
Price Target Difference	59.64%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 12, 2023. It was a reverse split with a ratio of 1:16.

Last Split Date	Sep 12, 2023
Split Type	Reverse
Split Ratio	1:16

Scores

DNTH has an Altman Z-Score of 48.28 and a Piotroski F-Score of 2.

Altman Z-Score	48.28
Piotroski F-Score	2